TKNO: Alpha Teknova, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 294.26
Enterprise Value ($M) 304.04
Book Value ($M) 82.39
Book Value / Share 1.55
Price / Book 3.57
NCAV ($M) 6.40
NCAV / Share 0.12
Price / NCAV 45.97

Profitability (mra)
Return on Invested Capital (ROIC) -0.24
Return on Assets (ROA) -0.21
Return on Equity (ROE) -0.30

Liquidity (mrq)
Quick Ratio 3.21
Current Ratio 3.82

Balance Sheet (mrq) ($M)
Current Assets 42.78
Assets 118.77
Liabilities 36.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 37.74
Operating Income -26.15
Net Income -26.75

Cash Flow Statement (mra) ($M)
Cash From Operations -12.39
Cash from Investing -27.27
Cash from Financing 14.89

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
07-19 13D Telegraph Hill Partners IV, L.P. 70.80 47.21

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-11 129,093 390,338 33.07
2025-03-10 135,657 544,784 24.90
2025-03-07 102,369 399,644 25.62
2025-03-06 197,430 508,038 38.86

(click for more detail)

Similar Companies
TARA – Protara Therapeutics, Inc. TBPH – Theravance Biopharma, Inc.
TCRX – TScan Therapeutics, Inc. TLPH – Talphera, Inc.
TNGX – Tango Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io